Thyssenkrupp's October Spin-Off Nears as Analysts and Management Diverge on the Road Ahead

Thyssenkrupp's TK Accelis spin-off nears legal completion in Oct 2026; shares up 57% YTD, analysts split on outlook.

The countdown to Thyssenkrupp's most consequential corporate action in years is now measured in weeks. With the legal completion of the TK Accelis spin-off slated for late October 2026, investors are positioning themselves for a restructuring play that has already reshaped the share price — even though the transaction itself has yet to take effect.

Shareholders gave the green light at an extraordinary general meeting on 7 August to carve out 49 percent of the materials distribution business and list it separately. The newly formed TK Accelis Group AG & Co. KGaA will initially remain 51 percent owned by Thyssenkrupp after its stock market debut, with that stake scheduled to be gradually reduced to 30 percent. For every 20 Thyssenkrupp shares held, investors will receive one limited partnership share in the new entity.

The mechanics matter here. The transaction only becomes legally binding once it is entered into the commercial register, an event expected at the end of October 2026. Until then, the spin-off remains a declared but unfinished structural measure. What this means in practice: holding the stock today secures future participation in an independently listed materials trader, while the parent company's day-to-day operations remain unchanged in the interim.

A Conglomerate Reorganizing on Multiple Fronts

The spin-off is just one thread in a broader corporate reweaving. The marine division TKMS raised its growth forecast in early August, adding a defensive bright spot to the portfolio. The hydrogen subsidiary Nucera, by contrast, has hit turbulence: it abandoned plans for in-house mass production of SOEC electrolysis cells and booked a special charge of roughly EUR 30 million in the fourth quarter, largely driven by a write-down on its pilot facility. The earnings outlook for Nucera for the current fiscal year has been trimmed to a range of minus EUR 105 million to minus EUR 75 million, with revenue expectations for the green hydrogen business reduced to EUR 100–130 million.

This mixed picture — growth in defence, a setback in hydrogen, and the impending independence of the materials business — means investors will increasingly need to evaluate Thyssenkrupp's divisions on a standalone basis once TK Accelis trades separately.

The Numbers Tell a Two-Sided Story

The third quarter of fiscal 2025/2026 delivered solid headline figures: revenue climbed to EUR 8.8 billion from EUR 8.2 billion in the year-ago period, with adjusted EBIT of EUR 183 million. Management pointed to progress on strategic realignment. Yet in the same breath, the group lowered its full-year revenue guidance — a signal that operational gains and overall growth momentum are not moving in lockstep.

That contradiction has produced an unusual dynamic in the market. Analysts have largely responded with optimism despite the reduced forecast. The DZ Bank upgraded the stock from "Hold" to "Buy" on 21 August, lifting its fair value from EUR 11 to EUR 16. Deutsche Bank Research had already reaffirmed its "Buy" rating with a EUR 16 price target on 14 August. Citi and Bank of America also raised their targets in mid-to-late August. JP Morgan struck a more cautious note, holding its "Neutral" stance on 14 August — a reminder that the bullish consensus is not unanimous.

Trading Near the Ceiling

The share price has absorbed the mixed signals with notable resilience. Over the past 30 days, the stock has gained 23 percent, and it is up 57 percent since the start of the year. The 10 percent advance since the extraordinary general meeting three weeks ago reflects growing confidence in the spin-off timeline. On Friday, the shares closed at EUR 14.67, down 1.2 percent on the day — a modest pullback after a 9.2 percent weekly gain that had pushed the stock within striking distance of its 52-week high of EUR 15.18, reached on 28 August. The current gap to that peak stands at just 3.4 percent.

The proximity to the yearly high coincides with a period of intense structural repositioning. Between now and the October legal completion, the TK Accelis spin-off is likely to dominate investor attention — the central question being whether the operational momentum from the third quarter can offset the dimmed revenue outlook. The analyst upgrades suggest a significant portion of the market is betting on the restructuring story over near-term growth metrics. The JP Morgan hold, however, keeps a measure of skepticism alive in a rally that has already traveled far.